The global market of Melatonin has reflected a diverging price trend in December 2025. The diverging price trend was shaped by contrasting procurement behaviour across the key export regions. The sentiment of Melatonin market was cautious and pricing directions have differed between export markets of the US and China. The divergence was the result of different market dynamics in the downstream market ahead of early 2026 production cycles. The domestic nutraceutical and pharmaceutical manufacturers of the US have secured the inventory covers strongly before the year-end which has reflected a forward-looking procurement planning and seasonal anticipation. The Chinese downstream manufacturers have entered the December with sufficient stock which was accumulated from the previous production cycles and chose to reassess their inventory position instead of fresh purchases. The imbalance in the buying momentum has created uneven pricing pressure which has highlighted how inventory discipline and demand timing can influence a market movement.
